Literature DB >> 12927659

Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment.

Efrat Aharonovich1, Edward Nunes, Deborah Hasin.   

Abstract

Cognitive-behavioral therapy (CBT) depends on adequate cognitive functioning in patients, but prolonged cocaine use may impair cognitive functioning. Therefore, cognitive impairment may impede the ability of cocaine abusers to benefit from CBT. To begin to address this issue, we investigated the relationship between cognitive impairment and two treatment outcomes, therapy completion and abstention. Eighteen carefully screened non-depressed cocaine-dependent patients in a psychopharmacological clinical trial were administered the MicroCog computerized battery to assess cognitive performance at treatment entry. T-tests were used to compare cognitive functioning between completers (patients remaining in treatment at least 12 weeks) and dropouts. The results indicated that treatment completers had demonstrated significantly better cognitive performance at baseline than patients who dropped out of treatment. Cognitive domains that significantly distinguished between treatment completers and dropouts were attention, mental reasoning and spatial processing. This study provides preliminary evidence that cognitive impairments may decrease treatment retention and abstinence in CBT of cocaine dependence.

Entities:  

Mesh:

Year:  2003        PMID: 12927659      PMCID: PMC5804498          DOI: 10.1016/s0376-8716(03)00092-9

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  14 in total

1.  Dose-related neurobehavioral effects of chronic cocaine use.

Authors:  K I Bolla; R Rothman; J L Cadet
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

2.  Demographic variables and microCog performance: relationships for VA patients under treatment for substance abuse.

Authors:  S J Lopez; J J Ryan; S W Sumerall; J W Lichtenberg; D Glasnapp; T S Krieshok; J N Van Fleet
Journal:  Psychol Rep       Date:  2001-02

3.  Differential effects of cocaine and cocaine alcohol on neurocognitive performance.

Authors:  K I Bolla; F R Funderburk; J L Cadet
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

4.  A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy.

Authors:  K M Carroll; B J Rounsaville; F H Gawin
Journal:  Am J Drug Alcohol Abuse       Date:  1991-09       Impact factor: 3.829

Review 5.  Improvement of phase III psychotropic drug trials by intensive phase II work.

Authors:  D F Klein
Journal:  Neuropsychopharmacology       Date:  1991-06       Impact factor: 7.853

6.  Neuropsychological deficits in chronic cocaine abusers.

Authors:  A Ardila; M Rosselli; S Strumwasser
Journal:  Int J Neurosci       Date:  1991-03       Impact factor: 2.292

7.  Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence.

Authors:  J Berry; W G van Gorp; D S Herzberg; C Hinkin; K Boone; L Steinman; J N Wilkins
Journal:  Drug Alcohol Depend       Date:  1993-05       Impact factor: 4.492

8.  Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients.

Authors:  G Teichner; M D Horner; R T Harvey
Journal:  Int J Neurosci       Date:  2001       Impact factor: 2.292

9.  Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence.

Authors:  Victoria Di Sclafani; Marina Tolou-Shams; Leonard J Price; George Fein
Journal:  Drug Alcohol Depend       Date:  2002-04-01       Impact factor: 4.492

10.  Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects.

Authors:  P M Maude-Griffin; J M Hohenstein; G L Humfleet; P M Reilly; D J Tusel; S M Hall
Journal:  J Consult Clin Psychol       Date:  1998-10
View more
  114 in total

Review 1.  Choosing a behavioral therapy platform for pharmacotherapy of substance users.

Authors:  Kathleen M Carroll; Thomas R Kosten; Bruce J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2004-08-16       Impact factor: 4.492

Review 2.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 3.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 4.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

5.  Self-efficacy for cocaine abstinence: pretreatment correlates and relationship to outcomes.

Authors:  Sara L Dolan; Rosemarie A Martin; Damaris J Rohsenow
Journal:  Addict Behav       Date:  2007-12-07       Impact factor: 3.913

Review 6.  Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.

Authors:  Alexander M Lopez; Daniel Weintraub; Daniel O Claassen
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

7.  Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression.

Authors:  Matthew J Worley; Susan R Tate; Eric Granholm; Sandra A Brown
Journal:  J Consult Clin Psychol       Date:  2014-03-03

8.  Cognition, commitment language, and behavioral change among cocaine-dependent patients.

Authors:  Efrat Aharonovich; Paul C Amrhein; Adam Bisaga; Edward V Nunes; Deborah S Hasin
Journal:  Psychol Addict Behav       Date:  2008-12

9.  Who Do You Think Is in Control in Addiction? A Pilot Study on Drug-related Locus of Control Beliefs.

Authors:  Karen D Ersche; Abigail J Turton; Tim Croudace; Jan Stochl
Journal:  Addict Disord Their Treat       Date:  2012-12

10.  Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.

Authors:  Andy C Dean; Edythe D London; Catherine A Sugar; Christina M R Kitchen; Aimee-Noelle Swanson; Keith G Heinzerling; Ari D Kalechstein; Steven Shoptaw
Journal:  Drug Alcohol Depend       Date:  2009-07-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.